Gravenbos Farma

Active Risk: not assessed

Private limited companyfounded 2021active for 5 yearsEsdoornlaan 1, 1770 Liedekerke, BelgiumKBO/BCE: BE 0769.920.078

Summary

Gravenbos Farma has a registered holding activity and consists mainly of financial fixed assets. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €220,755 and a net result of €80,059. Equity has been growing by about 68% per year since 2022. Its solvency ranks better than 30% of 10,826 sector peers (NACE 70, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

Gravenbos FarmaActive

Risk analysis Report Compare

Official details

Source: KBO

Status: Active since 21-06-2021 Normal situation
Activity: Activities of head offices NACE 70100and 3 others
Establishment unit: 2.323.102.884 1770 Liedekerke, since 01-10-2021
Financial year end: 31 December
Peppol: Reachable since 21-10-2026

Company details

Board and ownership

Board

Droeshout KaterinaDirector · since 15-06-2021

Holdings: Shares in 1 company APOTHEEK DAEM

Board & ownership

Financial position

Holding: outside the score modelBankruptcy probability: sector outside the model

Annual accounts 2025

Gross margin: €139,075; ▲ 4.1%
Turnover: ≈ €230,000; estimated
Profit: €80,059; ▲ 3.7%
Equity: €220,755; ▲ 56.9%
Total assets: €753,836; ▲ 4.5%

2025 accounts filed 31 days after the deadline

Financials

Signalsraises risk2025 accounts filed 31 days lateShow the evidence

Checked score

Outside the general model

Holding: general score not applicable

The company has a registered holding activity. Financial fixed assets make up more than half of its assets. The general model for operating companies does not fit such a balance sheet, so there is no score and no financial strength.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.

raises risk

2025 accounts filed 31 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 4 filings

Deviation from the deadline

2025

31 days late

2024

106 days late

2023

30 days late

2022

31 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 50 days after the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (3 of the last 4 accounts filed within 30 days either side of that date).

Companies Code · seven months

Where today falls in the filing period

04-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Key points

Positive: Equity rose in 2025from €140,695 to €220,755 ▲ 56.9% View

Recent changes

12-06-2023 · Gazette deed General meeting · Purpose change
23-06-2021 · Gazette deed Incorporation

All 9 events

Comparable companies

These companies have the same main activity as Gravenbos Farma: activities of head offices (NACE 70100). They are comparable in size and age: total assets between €675,000 and €927,000, founded between 2020 and 2021.

Company	Total assets	Gross margin
Gravenbos Farma Liedekerke	€753,836	€139,075
WALRAVENS INVEST Lennik	€697,945	€162,648
KVJM Keerbergen	€698,676	€142,532
DV TECHNICS Juprelle	€729,892	€136,249
JAMA MANAGEMENT Liège	€674,900	€127,502
Spiaggia Knokke-Heist	€927,209	€133,535
MAKI HOUSE Vorst	€720,522	€156,299

Full comparison

Key facts about Gravenbos Farma

What is the company number of Gravenbos Farma?: The company number of Gravenbos Farma is 0769.920.078. The VAT number is the same number with BE in front: BE 0769.920.078.
Where is Gravenbos Farma based?: The registered office is at Esdoornlaan 1, 1770 Liedekerke.Company details
What does Gravenbos Farma do?: According to the KBO register, the main activity is activities of head offices (NACE 70100).
What is the legal form of Gravenbos Farma?: The legal form of Gravenbos Farma is Private limited company (BV).
When was Gravenbos Farma founded?: Gravenbos Farma was founded on 21-06-2021.
Is Gravenbos Farma still active?: Yes, Gravenbos Farma is an active enterprise in the KBO register.
What is the turnover of Gravenbos Farma?: The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €139,075 and 99 comparable companies (NACE 70). It probably lies between €180,000 and €300,000.Financials
Is Gravenbos Farma profitable?: In financial year 2025, Gravenbos Farma made a profit of €80,059.
Where can I find the annual accounts of Gravenbos Farma?: Gravenbos Farma filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Gravenbos Farma due?: Gravenbos Farma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline